Nothing Special   »   [go: up one dir, main page]

Raimondi et al., 2020 - Google Patents

Non-coding RNAs in multiple myeloma bone disease pathophysiology

Raimondi et al., 2020

View HTML
Document ID
14118153183624177727
Author
Raimondi L
De Luca A
Giavaresi G
Raimondo S
Gallo A
Taiana E
Alessandro R
Rossi M
Neri A
Viglietto G
Amodio N
Publication year
Publication venue
Non-coding RNA

External Links

Snippet

Bone remodeling is uncoupled in the multiple myeloma (MM) bone marrow niche, resulting in enhanced osteoclastogenesis responsible of MM-related bone disease (MMBD). Several studies have disclosed the mechanisms underlying increased osteoclast formation and …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology

Similar Documents

Publication Publication Date Title
He et al. The roles and mechanisms of lncRNAs in liver fibrosis
Razmara et al. Non-coding RNAs in cartilage development: an updated review
Li et al. Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis
Rinnerthaler et al. miR-16-5p is a stably-expressed housekeeping microRNA in breast cancer tissues from primary tumors and from metastatic sites
Raimondo et al. Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma
Sepramaniam et al. Circulating microRNAs as biomarkers of acute stroke
Liao et al. Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing
Kutsche et al. Combined experimental and system-level analyses reveal the complex regulatory network of miR-124 during human neurogenesis
Aurilia et al. The involvement of long non-coding RNAs in bone
Liu et al. MicroRNA-944 affects cell growth by targeting EPHA7 in non-small cell lung cancer
Raimondi et al. Non-coding RNAs in multiple myeloma bone disease pathophysiology
Kim et al. STAT3 inhibitor ODZ10117 suppresses glioblastoma malignancy and prolongs survival in a glioblastoma xenograft model
Watanabe et al. A human skin model recapitulates systemic sclerosis dermal fibrosis and identifies COL22A1 as a TGFβ early response gene that mediates fibroblast to myofibroblast transition
Chen et al. Advances of exosomal miRNAs in breast cancer progression and diagnosis
Yang et al. Identification of recurrence related microRNAs in hepatocellular carcinoma after surgical resection
Federico et al. Circulating microRNAs and their role in multiple myeloma
Coppola et al. S-Adenosylmethionine inhibits cell growth and migration of triple negative breast cancer cells through upregulating MiRNA-34c and MiRNA-449a
Indio et al. Gene expression landscape of SDH-deficient gastrointestinal stromal tumors
Freire et al. Decreased mir-497-5p suppresses il-6 induced atrophy in muscle cells
Nikolova et al. Coupling miR/isomiR and mRNA expression signatures unveils new molecular layers of endometrial receptivity
Laudadio et al. ZNF281 promotes colon fibroblast activation in tgfβ1-induced gut fibrosis
Ronchetti et al. In silico characterization of miRNA and long non-coding RNA interplay in multiple myeloma
Dreher et al. TGF-β Induction of miR-143/145 is associated to exercise response by influencing differentiation and insulin signaling molecules in human skeletal muscle
Kuscu et al. Integrative analyses of circulating small RNAs and kidney graft transcriptome in transplant glomerulopathy
Araldi et al. LIMD2 regulates key steps of metastasis cascade in papillary thyroid cancer cells via MAPK crosstalk